Medicinova share price logo

Medicinova

NASDAQ: MNOV

$1.47

+0.01

(+0.34%)

Live

as on

Medicinova Stock Performance

as on November 10, 2026 at 6:33 am IST

  • Day's Low

    $1.42
    $1.47
    downward going graph

    3.40%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.22
    $3.90
    downward going graph

    17.01%

    Downside

    165.30%

    Upside

    downward going graph

Medicinova share price movements today

Previous Close
$1.46
Open
$1.44
Volume
338.1K
Market Cap
$71.9M
Day's Low - High
$1.42 - $1.47
52 Week Low - High
$1.22 - $3.90

Medicinova Historical Returns

1 Month Return
-3.95 %
3 Month Return
+ 8.96 %
1 Year Return
+ 2.82 %
3 Year Return
-18.44 %
5 Year Return
-59.1 %

Medicinova Stock Fundamentals & Key Indicators

Check Medicinova market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$71.9M

EPS (TTM)

-0.2172

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.72

Industry PE ratio

-3.15

PEG Ratio

-0.77

EBITDA

-11.0M

Revenue (TTM)

920.5K

Profit Margin

42.39%

Return On Equity TTM

-26.51%

Medicinova vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Medicinova with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$71.9M-59.10%-6.7242.39%0.00%
Neutral$101.5B7.32%-35.9528.00%0.00%
StrongBuy$46.5BNA66.6588.39%0.00%
StrongBuy$138.7B186.30%34.9485.57%0.00%
Buy$93.5B46.74%19.2685.77%0.41%

Stock Returns calculator for Medicinova Stock including INR - Dollar returns

The Medicinova stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Medicinova investment value today

Current value as on today

₹1,09,613

Returns

₹9,613

(+9.61%)

Returns from Medicinova Stock

₹3,521 (+3.52%)

Dollar Impact

₹6,092 (+6.09%)

Analyst Recommendation on Medicinova Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Medicinova. Average target price of $8.25

Medicinova Share Price Target

Get share price movements and forecasts by analysts on Medicinova.

What analysts predicted

82.18%UPSIDE

Target Price

$8.25

Current Price

$1.47

Analyzed by

7 Analysts

Target

$8.25

Medicinova target price $8.25, a slight upside of 82.18% compared to current price of $1.47. According to 7 analysts rating.

Indian Investors' Interest in Medicinova Stock

Search interest for Medicinova Stock has decreased by -91% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-91% versus previous 30 day period

Medicinova Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
0
0
0
0
0
Gross Profit
-
-
-
0
-
0
0
0
0
0
Operating Income
-3
-3
-3
-3
-3
-3
-3
-3
-2
-2
EBITDA
-2
-2
-2
-2
-2
-3
-3
-2
-2
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-2
-2
-2
-3
-3
-2
-2
-2
Income Tax Expense
-
-
-
0
-
-
-
0
-
-
Net Income
-2
-2
-2
-2
-2
-3
-3
-2
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
13.56%
6.53%
34.11%
6.75%
69.31%

Medicinova Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
4
-
1
-
0
Gross Profit
0
0
0
-
4
-
1
-
0
Operating Income
-13
-15
-14
-14
-10
-14
-9
-12
-13
EBITDA
-12
-15
-14
-14
-10
-14
-8
-11
-11
Interest Expense
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-14
-12
-13
-10
-14
-8
-11
-11
Income Tax Expense
-1
0
0
0
0
0
0
0
0
Net Income
-11
-14
-12
-13
-10
-14
-8
-11
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
0.00%
100.00%
0.00%
7.58%

Medicinova Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-2
-2
-2
-2
-3
-3
-2
-2
-2,314
Operating Cash Flow
-3
-2
-2
-1
-3
-2
-1
-2
-3
-1,920
Investing Cash Flow
-
0
0
0
-
-
0
-
0
-
Financing Cash Flow
-
-
-
-
-
-
-
0
-
-
Change in Cash
-3
-2
-2
-1
-3
-2
-1
-1
-3
-1,913

Medicinova Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-14
-12
-13
-10
-14
-8
-11
-11
Operating Cash Flow
-6
-9
-9
-10
-9
-12
-7
-10
-9
Investing Cash Flow
-84
0
0
0
0
-40
39
0
0
Financing Cash Flow
10
42
10
7
20
0
-
-
0
Change in Cash
3
34
1
-3
11
-52
32
-10
-9

Global Institutional Holdings in Medicinova

Check out the Institutions with significant holdings in Medicinova.

Funds
Holdings
3D Investment Partners Pte. Ltd.
9.88%
Vanguard
6.58%
Yuichi Iwaki
2.22%
BlackRock, Inc.
1.53%
VANGUARD INDEX FUNDS
1.24%

Medicinova News & Key Events

  • img

    Today's Timeline - 28 September

    Mon, 03:45 PM

    -

    MediciNova reports positive topline results from Phase 2 trial of MN-001 for treating hypertriglyceridemia and liver disease.

    Tue, 02:42 AM

    -

    MediciNova extends office lease to April 2030, indicating long-term stability and commitment to current operations.

Insights on Medicinova

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, MNOV stock has moved up by 9.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 935.8% return, outperforming this stock by 933.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 265.7% return, outperforming this stock by 284.1%

About Medicinova

MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United States. Its robust development pipeline features MN-166 (ibudilast), an oral agent with both anti-inflammatory and neuroprotective properties, currently being investigated for a range of neurological conditions. These include primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and various forms of substance dependence and addiction. The company's portfolio also comprises MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist aimed at treating acute asthma attacks; MN-001 (tipelukast), an orally available small molecule designed for fibrotic disorders like nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent intended for solid tumor oncology. MediciNova has established strategic partnerships with companies such as Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Angiogene Pharmaceuticals Ltd., and Meiji Seika Kaisha Ltd. Established in 2000, the company's headquarters are situated in La Jolla, California.
OrganisationMedicinova
Headquarters4275 Executive Square, La Jolla, CA, 92037, US
IndustryBiotechnology
CEOYuichi Iwaki

Key Management of Medicinova

Name

Title

Dr. Yuichi Iwaki M.D., Ph.D.

Co-Founder, President, CEO & Chairman

Dr. Kazuko Matsuda M.D., M.P.H., Ph.D.

Senior VP, Chief Medical Officer & Director

Dr. David H. Crean M.B.A., Ph.D.

Chief Business Officer

Mr. Jason J. Kruger CPA

CFO & Principal Financial Officer

FAQs

What is Medicinova share price today?

Medicinova share price today is $1.47 as on . Medicinova share today touched a day high of $1.47 and a low of $1.42.

What is the 52 week high and 52 week low for Medicinova share?

Medicinova share touched a 52 week high of $3.90 on and a 52 week low of $1.22 on . Medicinova stock price today i.e. is trending at $1.47,which is 62.31% down from its 52 week high and 20.49% up from its 52 week low.

What is Medicinova's market capitalisation today?

Medicinova market capitalisation is $0.00T as on .

How to invest in Medicinova Stock (MNOV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Medicinova on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Medicinova Stock (MNOV) from India?

Indian investors can start investing in Medicinova (MNOV) shares with as little as ₹93.92749786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.27 in Medicinova stock (as per the Rupee-Dollar exchange rate as on ). Based on Medicinova share’s latest price of $1.47 as on November 10, 2026 at 1:03 am IST, you will get 6.8027 shares of Medicinova. Learn more about fractional shares .

What are the returns that Medicinova has given to Indian investors in the last 5 years?

Medicinova stock has given -59.1% share price returns and 26.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?